Mike Huckman
Contributor since: 2008
Latest Articles
Amgen's D-mab Debate
Protalix's New Drug Likely to Win FDA Approval
Sanofi-Aventis Stock Recovering After Lantus Leak
How Bad Is Sanofi's Safety Scare?
Will New CEO Be Positive for Boston Scientific?
Invest in Crucell's Rabies Vaccine
Big Pharma's Pheeding Phrenzy
J&J Goes to Cougar Town
What's in Store for Amylin and Biogen Idec's Shareholder Meetings?
Will Intuitive Surgical's Appearance on 'Grey's Anatomy' Boost Sales?
Why Is Eli Lilly's CEO on the Media Offensive?
Will Boston Scientific's MADIT Defibrillators Make It?
Novartis Hires an Apprentice CFO
Amylin: I'm Not Taking Sides
Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth?
Vanda Snaps Up Victory from the Jaws of Defeat
Roche and Genentech: Get Your Act Together
Who Will Win the Amylin Battle?
Early Filing for Byetta: Will It Become a Blockbuster?
Why Did Dendreon Execs Cash Out on Friday?
The Sequenom Syndrome
Rare Failure for Roche's Avastin
The ABCs of Lilly: Amylin, Byetta & Carl
Biotech Analyst Eats Dendreon's Provenge Crow
Merck / Cardiome: Big Pharma Meets Baby Biotech
Dendreon: Freaky Friday
Which Diabetes Drugs Will Win Out?
Did Dendreon Play with Fire?
Biopharma, Especially Merck, Having a Good Week
Will Pfizer's Pancreatic Cancer Breakthrough Help the Stock?
When Will the Genentech Roller Coaster End?
Merck's Jumpin' Januvia Gets a Reprieve